This Stock Just Broke Out on a Major FDA Approval – Could Soar 22%–35%
Plus, our recommended trade with VKTX touched our first price target to deliver a potential 19% return from entry in just under two weeks.
Read MoreAuthor: Tara Young and Greg Patrick, Trades of the Day
This Stock Just Broke Out to a 52-Week High – Could Soar Another 38%
Plus, our recommended trade with ABBV touched our first price target to deliver a potential 12% return from entry in under two weeks.
Read MoreThis Stock is Up 20.3% Since Our Recommendation — And Looks Headed Even Higher
We’re now targeting a 15%-22% potential return in the next 2-5 months.
Read MoreThis Stock Just Broke Out of a Triangle — Analysts See 33% Upside
The combination of a record-breaking Q1 earnings beat, the imminent global launch of the company’s AI ad platform, and a fresh technical breakout makes this stock one of the more interesting setups on the board.
Read MoreThis AI “Picks-and-Shovels” Stock Just Broke Out — 55% Upside on the Table
The combination of a blowout earnings beat with record-setting guidance, a major DOJ overhang that just got significantly defused, and a fresh technical breakout makes this stock one of the more interesting setups on the board. Our trade idea is targeting a 32%–55% potential return.
Read More